Source: Annual Congress 2011 - New mechanisms in airway disease
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
T. Hassan, I. Oglesby, S. O‘Neill, C. Greene, G. McElvaney (Dublin, Ireland). microRNA regulation of the alpha-1 antitrypsin gene. Eur Respir J 2011; 38: Suppl. 55, 702

Member's Comments

No comment yet.

Related content which might interest you: Alpha-1 antitrypsin: functional analysis of novel variants Source: Research Seminar 2014 - Protein quality control in lung disease Year: 2014 Characterisation of alpha-1 antitrypsin protein expression and secretion in natural killer cells from healthy volunteers and alpha-1 antitrypsin deficiency patients Source: Virtual Congress 2021 – Novel insights into the pathogenesis of chronic lung diseases Year: 2021 Alpha-1 antitrypsin deficiency: clarifying the role of the putative protective threshold Source: Eur Respir J, 59 (2) 2101410; 10.1183/13993003.01410-2021 Year: 2022 Structural and clinical characterization of novel missense variants of SERPINA1 gene causing alpha-1 antitrypsin deficiency Source: International Congress 2019 – Crosstalk in chronic pulmonary diseases Year: 2019 Molecular characterization of novel PiS-like alleles identified in Spanish patients with Alpha-1 antitrypsin deficiency Source: International Congress 2018 – Functional genomics and COPD: new challenges Year: 2018 Long-term changes of elastin breakdown products in alpha-1 antitrypsin deficiency Source: Eur Respir J 2007; 30: Suppl. 51, 139s Year: 2007 Plasma circulating miRNAs as diagnostic and prognostic biomarkers in alpha-1 antitrypsin deficiency. Source: International Congress 2019 – Crosstalk in chronic pulmonary diseases Year: 2019 Rare alpha-1 antitrypsin mutations in the Irish population Source: Annual Congress 2012 - COPD inflammation and genes Year: 2012 Rare alpha-1 antitrypsin mutations in the Irish population Source: Annual Congress 2011 - Genetic and environmental risk factors for respiratory diseases Year: 2011 PiS and PiS-plus alleles. The importance of phasing gene variants in Alpha-1 Antitrypsin Deficiency Source: Virtual Congress 2020 – Intercellular communication in tissue remodelling of chronic lung diseases Year: 2020 Immunomodulation capacity of alpha-1 antitrypsin in regulation of CD14 molecules expression and secretion in human monocytes in vitro Source: Annual Congress 2011 - New mechanisms in airway disease Year: 2011 Alpha-1 antitrypsin (AAT) and alpha-2 macroglobulin (AMG) levels according to the stages and histological types in lung cancer Source: Annual Congress 2008 - Biology and prognosis in thoracic oncology Year: 2008 GSTP1 polymorphisms in patients with COPD and alpha-1 antitrypsin deficiency Source: Eur Respir J 2003; 22: Suppl. 45, 384s Year: 2003 A high purity alpha-1 antitrypsin (AAT) from human plasma, TAL6004 Source: Annual Congress 2009 - Treatment of airways disease Year: 2009 LSC - 2020 - Investigating the effect of Z alpha-1 antitrypsin expression on mitochondrial injury Source: Virtual Congress 2020 – Metabolic alterations and ageing in lung disease Year: 2020 Lung function in relation to emphysema development in alpha-1 antitrypsin deficiency Source: International Congress 2019 – Insights into physiological diagnostic services Year: 2019 Neutrophil elastase gene expression and relation with lung function in Alpha-1 Antitrypsin deficiency patients. Source: International Congress 2017 – Current molecular and genetic understanding of lung diseases Year: 2017 Pilot study for detection of alpha-1 antitrypsin deficiency in a targeted Argentinean population Source: Eur Respir J 2005; 26: Suppl. 49, 59s Year: 2005